Loading…

Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell

Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs...

Full description

Saved in:
Bibliographic Details
Published in:Analytical biochemistry 2018-07, Vol.553, p.1-6
Main Authors: Ma, Chengyao, Li, Yue, Wu, Hanqing, Ji, Junyang, Sun, Qianqian, Song, Yilin, Wang, Shen, Li, Xiang, Chen, Yong, Chen, Jianwei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313
cites cdi_FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313
container_end_page 6
container_issue
container_start_page 1
container_title Analytical biochemistry
container_volume 553
creator Ma, Chengyao
Li, Yue
Wu, Hanqing
Ji, Junyang
Sun, Qianqian
Song, Yilin
Wang, Shen
Li, Xiang
Chen, Yong
Chen, Jianwei
description Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs intake, have been reported rarely. Recent research has showed that cellular metabolic profiling coupled with ultra-flow liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (UFLC-Q-TOF-MS) and multivariable statistical analysis enables a good understanding of ACGs' effects on multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. As a result, 23 potential biomarkers (p 1) were identified, and 5 pathways (impact-value > 0.10) identified. The differential metabolites suggested that ACGs affected metabolomics pathways, including arginine and proline metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism and D-Glutamine and D-glutamate metabolism. [Display omitted] •A metabolomics approach by UFLC-Q-TOF-MS coupled with pattern recognition methods to ACGs for its antitumor activity.•Twenty three endogenous metabolites were identified and five metabolic pathways were found.•Barely visible differences in the metabolites between ACGs types were demonstrated.
doi_str_mv 10.1016/j.ab.2018.04.022
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2038273751</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000326971830188X</els_id><sourcerecordid>2038273751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313</originalsourceid><addsrcrecordid>eNp1kc1u1TAQhS0EoreFPSvkJZuEcZw_s0NVoUhFbGBtjZ1J66vEvtgOUp-Bl8bRLexYzWLO-TRnDmNvBNQCRP_-WKOpGxBjDW0NTfOMHQSovgIJ6jk7AICsml4NF-wypSOAEG3Xv2QXjRo6UK08sN9fKaMJS1idTRw9Lo_JJR5mnh-In0Imnx0uZZOdRW8p8pXsA3qX1l2F3gePlsJW3JZyuCfvfAF4jnzdluymuN3zSIWaC4SvuK4YHzlO5IPFaJ0PK3JLy_KKvZhxSfT6aV6xH59uvl_fVnffPn-5_nhXWdlBrqxqAY2wwrRWqs4qHGgy4zwaiSXh2Cs7oBU0ChjkbIaOzDDj0LadadUohbxi787cUww_N0pZry7tB6Dfc-gG5NgMcuh2KZylNoaUIs36FN1-vxag9wr0UaPRewUaWl0qKJa3T_TNrDT9M_z9eRF8OAuoZPzlKOpkHZXXTi6SzXoK7v_0P75kmY8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2038273751</pqid></control><display><type>article</type><title>Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell</title><source>ScienceDirect Journals</source><creator>Ma, Chengyao ; Li, Yue ; Wu, Hanqing ; Ji, Junyang ; Sun, Qianqian ; Song, Yilin ; Wang, Shen ; Li, Xiang ; Chen, Yong ; Chen, Jianwei</creator><creatorcontrib>Ma, Chengyao ; Li, Yue ; Wu, Hanqing ; Ji, Junyang ; Sun, Qianqian ; Song, Yilin ; Wang, Shen ; Li, Xiang ; Chen, Yong ; Chen, Jianwei</creatorcontrib><description>Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs intake, have been reported rarely. Recent research has showed that cellular metabolic profiling coupled with ultra-flow liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (UFLC-Q-TOF-MS) and multivariable statistical analysis enables a good understanding of ACGs' effects on multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. As a result, 23 potential biomarkers (p &lt; 0.05, VIP &gt;1) were identified, and 5 pathways (impact-value &gt; 0.10) identified. The differential metabolites suggested that ACGs affected metabolomics pathways, including arginine and proline metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism and D-Glutamine and D-glutamate metabolism. [Display omitted] •A metabolomics approach by UFLC-Q-TOF-MS coupled with pattern recognition methods to ACGs for its antitumor activity.•Twenty three endogenous metabolites were identified and five metabolic pathways were found.•Barely visible differences in the metabolites between ACGs types were demonstrated.</description><identifier>ISSN: 0003-2697</identifier><identifier>EISSN: 1096-0309</identifier><identifier>DOI: 10.1016/j.ab.2018.04.022</identifier><identifier>PMID: 29750943</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetogenins - pharmacology ; Adenocarcinoma - pathology ; Animals ; Annonaceous acetogenins ; Arginine - metabolism ; Cell Line, Tumor ; Drug Resistance, Multiple ; Drug Resistance, Neoplasm ; Glycerophospholipids - metabolism ; Humans ; Mammary adenocarcinoma ; Mammary Neoplasms, Animal - pathology ; Metabolomics ; Multidrug resistance ; Proline - metabolism</subject><ispartof>Analytical biochemistry, 2018-07, Vol.553, p.1-6</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313</citedby><cites>FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29750943$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Chengyao</creatorcontrib><creatorcontrib>Li, Yue</creatorcontrib><creatorcontrib>Wu, Hanqing</creatorcontrib><creatorcontrib>Ji, Junyang</creatorcontrib><creatorcontrib>Sun, Qianqian</creatorcontrib><creatorcontrib>Song, Yilin</creatorcontrib><creatorcontrib>Wang, Shen</creatorcontrib><creatorcontrib>Li, Xiang</creatorcontrib><creatorcontrib>Chen, Yong</creatorcontrib><creatorcontrib>Chen, Jianwei</creatorcontrib><title>Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell</title><title>Analytical biochemistry</title><addtitle>Anal Biochem</addtitle><description>Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs intake, have been reported rarely. Recent research has showed that cellular metabolic profiling coupled with ultra-flow liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (UFLC-Q-TOF-MS) and multivariable statistical analysis enables a good understanding of ACGs' effects on multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. As a result, 23 potential biomarkers (p &lt; 0.05, VIP &gt;1) were identified, and 5 pathways (impact-value &gt; 0.10) identified. The differential metabolites suggested that ACGs affected metabolomics pathways, including arginine and proline metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism and D-Glutamine and D-glutamate metabolism. [Display omitted] •A metabolomics approach by UFLC-Q-TOF-MS coupled with pattern recognition methods to ACGs for its antitumor activity.•Twenty three endogenous metabolites were identified and five metabolic pathways were found.•Barely visible differences in the metabolites between ACGs types were demonstrated.</description><subject>Acetogenins - pharmacology</subject><subject>Adenocarcinoma - pathology</subject><subject>Animals</subject><subject>Annonaceous acetogenins</subject><subject>Arginine - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Drug Resistance, Multiple</subject><subject>Drug Resistance, Neoplasm</subject><subject>Glycerophospholipids - metabolism</subject><subject>Humans</subject><subject>Mammary adenocarcinoma</subject><subject>Mammary Neoplasms, Animal - pathology</subject><subject>Metabolomics</subject><subject>Multidrug resistance</subject><subject>Proline - metabolism</subject><issn>0003-2697</issn><issn>1096-0309</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1TAQhS0EoreFPSvkJZuEcZw_s0NVoUhFbGBtjZ1J66vEvtgOUp-Bl8bRLexYzWLO-TRnDmNvBNQCRP_-WKOpGxBjDW0NTfOMHQSovgIJ6jk7AICsml4NF-wypSOAEG3Xv2QXjRo6UK08sN9fKaMJS1idTRw9Lo_JJR5mnh-In0Imnx0uZZOdRW8p8pXsA3qX1l2F3gePlsJW3JZyuCfvfAF4jnzdluymuN3zSIWaC4SvuK4YHzlO5IPFaJ0PK3JLy_KKvZhxSfT6aV6xH59uvl_fVnffPn-5_nhXWdlBrqxqAY2wwrRWqs4qHGgy4zwaiSXh2Cs7oBU0ChjkbIaOzDDj0LadadUohbxi787cUww_N0pZry7tB6Dfc-gG5NgMcuh2KZylNoaUIs36FN1-vxag9wr0UaPRewUaWl0qKJa3T_TNrDT9M_z9eRF8OAuoZPzlKOpkHZXXTi6SzXoK7v_0P75kmY8</recordid><startdate>20180715</startdate><enddate>20180715</enddate><creator>Ma, Chengyao</creator><creator>Li, Yue</creator><creator>Wu, Hanqing</creator><creator>Ji, Junyang</creator><creator>Sun, Qianqian</creator><creator>Song, Yilin</creator><creator>Wang, Shen</creator><creator>Li, Xiang</creator><creator>Chen, Yong</creator><creator>Chen, Jianwei</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180715</creationdate><title>Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell</title><author>Ma, Chengyao ; Li, Yue ; Wu, Hanqing ; Ji, Junyang ; Sun, Qianqian ; Song, Yilin ; Wang, Shen ; Li, Xiang ; Chen, Yong ; Chen, Jianwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acetogenins - pharmacology</topic><topic>Adenocarcinoma - pathology</topic><topic>Animals</topic><topic>Annonaceous acetogenins</topic><topic>Arginine - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Drug Resistance, Multiple</topic><topic>Drug Resistance, Neoplasm</topic><topic>Glycerophospholipids - metabolism</topic><topic>Humans</topic><topic>Mammary adenocarcinoma</topic><topic>Mammary Neoplasms, Animal - pathology</topic><topic>Metabolomics</topic><topic>Multidrug resistance</topic><topic>Proline - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Chengyao</creatorcontrib><creatorcontrib>Li, Yue</creatorcontrib><creatorcontrib>Wu, Hanqing</creatorcontrib><creatorcontrib>Ji, Junyang</creatorcontrib><creatorcontrib>Sun, Qianqian</creatorcontrib><creatorcontrib>Song, Yilin</creatorcontrib><creatorcontrib>Wang, Shen</creatorcontrib><creatorcontrib>Li, Xiang</creatorcontrib><creatorcontrib>Chen, Yong</creatorcontrib><creatorcontrib>Chen, Jianwei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Analytical biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Chengyao</au><au>Li, Yue</au><au>Wu, Hanqing</au><au>Ji, Junyang</au><au>Sun, Qianqian</au><au>Song, Yilin</au><au>Wang, Shen</au><au>Li, Xiang</au><au>Chen, Yong</au><au>Chen, Jianwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell</atitle><jtitle>Analytical biochemistry</jtitle><addtitle>Anal Biochem</addtitle><date>2018-07-15</date><risdate>2018</risdate><volume>553</volume><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0003-2697</issn><eissn>1096-0309</eissn><abstract>Although annonaceous acetogenins (ACGs) have been reported to have antitumor activity for over three decades, and many of the underlying mechanism of ACGs on cancer have been clarified, there are still outstanding issues. In particular, the changes of small metabolite in cancer cells, caused by ACGs intake, have been reported rarely. Recent research has showed that cellular metabolic profiling coupled with ultra-flow liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (UFLC-Q-TOF-MS) and multivariable statistical analysis enables a good understanding of ACGs' effects on multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells. As a result, 23 potential biomarkers (p &lt; 0.05, VIP &gt;1) were identified, and 5 pathways (impact-value &gt; 0.10) identified. The differential metabolites suggested that ACGs affected metabolomics pathways, including arginine and proline metabolism, glycerophospholipid metabolism, taurine and hypotaurine metabolism, alanine, aspartate and glutamate metabolism and D-Glutamine and D-glutamate metabolism. [Display omitted] •A metabolomics approach by UFLC-Q-TOF-MS coupled with pattern recognition methods to ACGs for its antitumor activity.•Twenty three endogenous metabolites were identified and five metabolic pathways were found.•Barely visible differences in the metabolites between ACGs types were demonstrated.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29750943</pmid><doi>10.1016/j.ab.2018.04.022</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-2697
ispartof Analytical biochemistry, 2018-07, Vol.553, p.1-6
issn 0003-2697
1096-0309
language eng
recordid cdi_proquest_miscellaneous_2038273751
source ScienceDirect Journals
subjects Acetogenins - pharmacology
Adenocarcinoma - pathology
Animals
Annonaceous acetogenins
Arginine - metabolism
Cell Line, Tumor
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Glycerophospholipids - metabolism
Humans
Mammary adenocarcinoma
Mammary Neoplasms, Animal - pathology
Metabolomics
Multidrug resistance
Proline - metabolism
title Metabolomics analysis of the potential anticancer mechanism of annonaceous acetogenins on a multidrug resistant mammary adenocarcinoma cell
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T14%3A06%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolomics%20analysis%20of%20the%20potential%20anticancer%20mechanism%20of%20annonaceous%20acetogenins%20on%20a%20multidrug%20resistant%20mammary%20adenocarcinoma%20cell&rft.jtitle=Analytical%20biochemistry&rft.au=Ma,%20Chengyao&rft.date=2018-07-15&rft.volume=553&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0003-2697&rft.eissn=1096-0309&rft_id=info:doi/10.1016/j.ab.2018.04.022&rft_dat=%3Cproquest_cross%3E2038273751%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c350t-c940ab1c1b4c395c9a7edb8f8b3a011869c7ac1e81073fb75eb7fa7445b498313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2038273751&rft_id=info:pmid/29750943&rfr_iscdi=true